Trial Profile
Phase II trial of olodaterol/tiotropium bromide in patients with chronic obstructive pulmonary disease.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Olodaterol/tiotropium bromide (Primary) ; Tiotropium bromide
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim (Canada)
- 05 Nov 2010 New trial record.